Effect of liver disease in kidney transplant recipients on cyclosporine dose and metabolite levels.
Alfurayh
O
O
Section of Nephrology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Sobh
M
M
Minhas
M
M
Almeshari
K
K
Alshaibani
K
K
Qunibi
W
W
Aesha
H
H
Taher
S
S
D000410:Alanine Transaminase / Q000097:blood; D000704:Analysis of Variance; D016572:Cyclosporine / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008107:Liver Diseases / Q000150:complications*; D008111:Liver Function Tests; D008297:Male; D013997:Time Factors
D016572:Cyclosporine; D000410:Alanine Transaminase